Trial reportAesthetic surgery journal2026
Internal Nasal Dilators After Septorhinoplasty: A Randomized Controlled Trial of Functional and Aesthetic Outcomes.
Trial report in Aesthetic surgery journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative nasal obstruction and asymmetry can compromise satisfaction after rhinoplasty. Internal nasal dilators (INDs) may support early healing by maintaining valve patency and symmetry, but their postoperative efficacy has not been systematically evaluated.
objectivesThe aim of this study was to determine whether IND use after septorhinoplasty improves functional, aesthetic, and symmetry outcomes compared with standard care.
methodsIn this single-center, randomized, single-blinded trial, 128 adults undergoing primary septorhinoplasty were allocated (1:1) to IND plus standard care or standard care alone. Assessments were performed at baseline, 3 months, and 12 months using the validated Standardized Cosmesis and Health Nasal Outcomes Survey (SCHNOS) and a nostril-symmetry item (0 = perfect, 4 = very asymmetrical). The primary outcome was patient-reported nostril symmetry; secondary outcomes included functional and aesthetic SCHNOS scores, comfort, and adverse events.
resultsBaseline characteristics were comparable. Nostril-symmetry scores favored the IND group at 3 months (0.78 ± 0.92 vs 1.42 ± 1.09; P = .001) and 12 months (0.46 ± 0.71 vs 1.40 ± 1.20; P < .001). Functional SCHNOS improved in both groups, with a slightly greater gain in the IND group at 12 months (+10.2 ± 4.1 vs +7.9 ± 4.4; P = .048). Aesthetic SCHNOS scores improved similarly across groups (P = .73). Device comfort was high, as measured by a visual analog scale (VAS 8.1 ± 1.4/10), and no device-related complications occurred.
conclusionsINDs improved postoperative nostril symmetry and maintained favorable functional and aesthetic outcomes without added risk or discomfort. These findings support the adjunctive use of INDs to enhance symmetry and patient satisfaction after rhinoplasty. LEVEL OF EVIDENCE: 2 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.